The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken ...

Following its acquisition of Silk Road in September, Boston Scientific said it plans to consolidate the company’s work in ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Boston Scientific's strong history, margins, and pipeline make it a buy despite other analysts' Hold rating, with 15% growth ...

BSX's Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal and pulmonary treatment options.

Boston Scientific will close Silk Road Medical’s headquarters in Sunnyvale, California, after it bought the maker of stroke prevention products in September. Spokesperson Chanel Hastings wrote ...

The prospective, multicenter ROADSTER 3 postapproval trial is evaluating the safety and effectiveness of transcarotid artery re ...

Canaccord Genuity maintained a Buy rating on Boston Scientific (NYSE:BSX) and increased the stock's price target to $98 from $88. The adjustment follows the successful acquisition of Silk Road ...

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...

In fact, there has been a 58% decline in the weekly pace of job cuts for tech workers in the Bay Area that their employers ...

Charting, Price Performance, News & Related Contracts.